Pre-eclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?
Carregando...
Data
2021-01-01
Autores
De Oliveira, Leandro Gustavo [UNESP]
Debs Diniz, Angelica Lemos
Campos Prado, Caio Antonio de
Da Cunha Filho, Edson Vieira
Pereira De Souza, Francisco Lazaro
Korkes, Henri Augusto
Ramos, Jose Geraldo
Costa, Maria Laura
Correa Junior, Mario Dias
Sass, Nelson
Título da Revista
ISSN da Revista
Título de Volume
Editor
Federacao Brasileira Soc Ginecologia & Obstetricia-febrasgo
Resumo
Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective a difficult task. In addition, the costs related to screening protocols, the heterogeneity of the most affected populations and the lack of highly effective prevention methods reduce the potential of current available algorithms for screening. Thus, the National Specialized Commission of Hypertension in Pregnancy of the Brazilian Association of Gynecology and Obstetrics Federation (Febrasgo, in the Portuguese acronym) (NSC Hypertension in Pregnancy of the Febrasgo) considers that there are no screening algorithms to be implemented in the country to date and advocates that Aspirin and calcium should be widely used.
Descrição
Palavras-chave
preeclampsia, screening, prevention, aspirin, calcium
Como citar
Revista Brasileira De Ginecologia E Obstetricia. Rio De Janeiro Rj: Federacao Brasileira Soc Ginecologia & Obstetricia-febrasgo, v. 43, n. 1, p. 61-65, 2021.